SPHK1 and acute myeloid leukemia: Targeting SPHK1 with the selective inhibitor MP-A08 induces caspase-dependent apoptotic cell death in AML cell lines, primary AML patient cells and LSPCs, while sparing normal hematopoietic progenitor cells [8,16,17].